Our annual ranking of America's largest corporations

Industries
Revenues Profits
Rank Company Fortune 500 rank $ millions % change from 2009 $ millions % change from 2009
1 Pfizer 31 67,809.0 35.6 8,257.0 -4.4
2 Johnson & Johnson 40 61,587.0 -0.5 13,334.0 8.7
3 Merck 53 45,987.0 67.7 861.0 -93.3
4 Abbott Laboratories 69 35,166.7 14.3 4,626.2 -19.5
5 Eli Lilly 115 23,076.0 5.7 5,069.5 17.1
6 Bristol-Myers Squibb 131 19,484.0 -9.9 3,102.0 -70.8
7 Amgen 163 15,053.0 2.8 4,627.0 0.5
8 Gilead Sciences 299 7,949.4 13.4 2,901.3 10.1
9 Mylan 418 5,450.5 7.0 345.1 48.4
10 Allergan 457 4,919.4 9.2 0.6 -99.9
11 Biogen Idec 476 4,716.4 7.7 1,005.3 3.6
12 Genzyme 487 4,535.9 0.5 422.1 -0.0
Rank Company Revenues % Assets % Stockholders'
Equity %
1 Pfizer 12.2 4.2 9.4
2 Johnson & Johnson 21.7 13.0 23.6
3 Merck 1.9 0.8 1.6
4 Abbott Laboratories 13.2 7.8 20.7
5 Eli Lilly 22.0 16.4 40.8
6 Bristol-Myers Squibb 15.9 10.0 19.7
7 Amgen 30.7 10.6 19.3
8 Gilead Sciences 36.5 25.0 49.5
9 Mylan 6.3 3.0 9.6
10 Allergan 0.0 0.0 0.0
11 Biogen Idec 21.3 12.4 18.6
12 Genzyme 9.3 3.9 5.6
Earnings Per Share Total Return to Investors Employees
Rank Company 2000-2010 Annual growth (%) 2000-2010 Annual rate (%) 2010 (%) Number % change from 2009
1 Pfizer 5.6 -6.0 0.6 110,600 -5.1
2 Johnson & Johnson 10.9 4.0 -0.6 114,000 -1.3
3 Merck -20.8 -5.3 2.8 94,000 -6.0
4 Abbott Laboratories 5.2 3.1 -8.2 91,440 25.5
5 Eli Lilly 5.1 -6.3 3.8 38,350 -5.0
6 Bristol-Myers Squibb -2.7 -5.2 10.2 27,000 -3.6
7 Amgen 16.4 -1.5 -3.0 17,250 0.9
8 Gilead Sciences N.A. 21.5 -16.2 4,000 3.3
9 Mylan 2.6 7.1 14.7 13,000 -7.1
10 Allergan -45.4 4.4 9.3 9,200 10.8
11 Biogen Idec 44.4 0.6 25.3 4,850 2.1
12 Genzyme 8.8 4.7 45.3 10,100 -15.8
Issue date: May 23, 2011
Find your top companies
 High revenue growth  High profit growth
 High EPS growth  High return to investors
 Top 5 in its industry  Best company to work for
 Big employer  Small employer



Video

Rank # of Fortune 500 Companies
New York 57
California 53
Texas 51
Company Rank
Microsoft 38
Goldman Sachs 54
Intel 56
Company 2010 $ (millions)
Exxon Mobil $30,460.0
AT&T $19,864.0
Chevron $19,024.0
FAQ and methodology
Included in the survey are U.S. incorporated companies filing financial statements with a government agency. This includes private companies... More
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.